Matches in Wikidata for { <http://www.wikidata.org/entity/Q37578137> ?p ?o ?g. }
Showing items 1 to 98 of
98
with 100 items per page.
- Q37578137 description "article científic" @default.
- Q37578137 description "article scientifique" @default.
- Q37578137 description "articolo scientifico" @default.
- Q37578137 description "artigo científico" @default.
- Q37578137 description "artículu científicu espublizáu en 2009" @default.
- Q37578137 description "bilimsel makale" @default.
- Q37578137 description "scientific article published in August 2009" @default.
- Q37578137 description "vedecký článok" @default.
- Q37578137 description "vetenskaplig artikel" @default.
- Q37578137 description "videnskabelig artikel" @default.
- Q37578137 description "vědecký článek" @default.
- Q37578137 description "wetenschappelijk artikel" @default.
- Q37578137 description "wissenschaftlicher Artikel" @default.
- Q37578137 description "наукова стаття, опублікована в серпні 2009" @default.
- Q37578137 description "научни чланак" @default.
- Q37578137 description "مقالة علمية نشرت في أغسطس 2009" @default.
- Q37578137 name "Reappraisal of OMERACT 8 draft validation criteria for a soluble biomarker reflecting structural damage endpoints in rheumatoid arthritis, psoriatic arthritis, and spondyloarthritis: the OMERACT 9 v2 criteria" @default.
- Q37578137 name "Reappraisal of OMERACT 8 draft validation criteria for a soluble biomarker reflecting structural damage endpoints in rheumatoid arthritis, psoriatic arthritis, and spondyloarthritis: the OMERACT 9 v2 criteria." @default.
- Q37578137 name "Reappraisal of OMERACT 8 draft validation criteria for a soluble biomarker reflecting structural damage endpoints in rheumatoid arthritis, psoriatic arthritis, and spondyloarthritis: the OMERACT 9 v2 criteria." @default.
- Q37578137 type Item @default.
- Q37578137 label "Reappraisal of OMERACT 8 draft validation criteria for a soluble biomarker reflecting structural damage endpoints in rheumatoid arthritis, psoriatic arthritis, and spondyloarthritis: the OMERACT 9 v2 criteria" @default.
- Q37578137 label "Reappraisal of OMERACT 8 draft validation criteria for a soluble biomarker reflecting structural damage endpoints in rheumatoid arthritis, psoriatic arthritis, and spondyloarthritis: the OMERACT 9 v2 criteria." @default.
- Q37578137 label "Reappraisal of OMERACT 8 draft validation criteria for a soluble biomarker reflecting structural damage endpoints in rheumatoid arthritis, psoriatic arthritis, and spondyloarthritis: the OMERACT 9 v2 criteria." @default.
- Q37578137 prefLabel "Reappraisal of OMERACT 8 draft validation criteria for a soluble biomarker reflecting structural damage endpoints in rheumatoid arthritis, psoriatic arthritis, and spondyloarthritis: the OMERACT 9 v2 criteria" @default.
- Q37578137 prefLabel "Reappraisal of OMERACT 8 draft validation criteria for a soluble biomarker reflecting structural damage endpoints in rheumatoid arthritis, psoriatic arthritis, and spondyloarthritis: the OMERACT 9 v2 criteria." @default.
- Q37578137 prefLabel "Reappraisal of OMERACT 8 draft validation criteria for a soluble biomarker reflecting structural damage endpoints in rheumatoid arthritis, psoriatic arthritis, and spondyloarthritis: the OMERACT 9 v2 criteria." @default.
- Q37578137 P1433 Q37578137-44A1C1CE-AD7E-4279-A155-5AB2A262388B @default.
- Q37578137 P1476 Q37578137-0F18347C-9A82-442C-96E1-C437104D7513 @default.
- Q37578137 P2093 Q37578137-22DC1450-E155-45E8-8BBE-A6296E8C99DC @default.
- Q37578137 P2093 Q37578137-840296C7-2156-423F-A920-307561F9A9F1 @default.
- Q37578137 P304 Q37578137-3E2C2FFC-DC0B-4E3F-8926-E3CA48EEBD14 @default.
- Q37578137 P31 Q37578137-FD74C777-22D7-4556-B711-959D8AF2107F @default.
- Q37578137 P356 Q37578137-1D206F48-92BA-4895-811D-C4AE642E47DB @default.
- Q37578137 P407 Q37578137-EF7323C4-BB65-417D-BB00-E553AE602B14 @default.
- Q37578137 P433 Q37578137-D9B509DA-B55F-40CD-94EA-858F0BCE2BA7 @default.
- Q37578137 P478 Q37578137-10872152-BFBC-4746-BA15-4746E949EAC4 @default.
- Q37578137 P50 Q37578137-0B1D5787-0ED6-470B-BEC9-5AC6CD907B63 @default.
- Q37578137 P50 Q37578137-10BCE252-108A-482C-A34B-871AC22AF680 @default.
- Q37578137 P50 Q37578137-183BD0DB-3A7E-4BC7-9597-8A97EBA547C2 @default.
- Q37578137 P50 Q37578137-29C6006E-C0D1-47F4-9A11-4AC93849EAA2 @default.
- Q37578137 P50 Q37578137-360F52BC-D6DA-416B-8FFB-5F83B52B721C @default.
- Q37578137 P50 Q37578137-3CF7D118-3653-47A5-B961-1DA520B1CEDB @default.
- Q37578137 P50 Q37578137-47EB5E06-B391-44BC-A6A3-7ED786084C70 @default.
- Q37578137 P50 Q37578137-503F8A2E-98C4-414C-B1E6-57D2DCF1F615 @default.
- Q37578137 P50 Q37578137-662A0033-867E-4346-A9D7-D1015E63F738 @default.
- Q37578137 P50 Q37578137-9216A9B6-DCA5-47DA-9395-A33703DE7496 @default.
- Q37578137 P50 Q37578137-A2D83ED8-CB25-4BA6-B86F-2669FFDFB674 @default.
- Q37578137 P50 Q37578137-AC89A142-E61D-4ABC-B9EA-F6630B5A1E13 @default.
- Q37578137 P50 Q37578137-AEE23B46-2B26-4D7C-89F3-63BF7942795A @default.
- Q37578137 P50 Q37578137-C3757743-43F0-4474-B7EB-092DD56B33A4 @default.
- Q37578137 P50 Q37578137-C97BC94E-2B68-4F39-A8E4-73E213C1A123 @default.
- Q37578137 P50 Q37578137-D7B68780-6187-4FF2-A5AA-6582694BC7FC @default.
- Q37578137 P50 Q37578137-DF8C04AC-8D9C-4900-9BD8-2E6E64F2B51E @default.
- Q37578137 P50 Q37578137-E9EF573F-16B2-48C6-8CE2-6BB2A0F22F99 @default.
- Q37578137 P50 Q37578137-EE3114D5-EE02-4654-B5E1-0C79CC372197 @default.
- Q37578137 P50 Q37578137-F5D918EB-EA06-495F-B7CE-DFDB529FDED9 @default.
- Q37578137 P577 Q37578137-F7212FBC-8CA2-4C0F-98CC-E5E4AA212597 @default.
- Q37578137 P698 Q37578137-E94BD23B-A294-41D9-80D1-9FF41978B0F1 @default.
- Q37578137 P921 Q37578137-27DD3E55-AC3A-4579-B3D7-79CBD21A01BD @default.
- Q37578137 P921 Q37578137-8BCAA239-6A2F-4F14-9F1E-6319F5F3787D @default.
- Q37578137 P921 Q37578137-BB0614F0-6686-40EF-B400-9080F908E87D @default.
- Q37578137 P356 JRHEUM.090346 @default.
- Q37578137 P698 19671813 @default.
- Q37578137 P1433 Q7743623 @default.
- Q37578137 P1476 "Reappraisal of OMERACT 8 draft validation criteria for a soluble biomarker reflecting structural damage endpoints in rheumatoid arthritis, psoriatic arthritis, and spondyloarthritis: the OMERACT 9 v2 criteria" @default.
- Q37578137 P2093 "Maarten Boers" @default.
- Q37578137 P2093 "Paul-Peter Tak" @default.
- Q37578137 P304 "1785-1791" @default.
- Q37578137 P31 Q13442814 @default.
- Q37578137 P356 "10.3899/JRHEUM.090346" @default.
- Q37578137 P407 Q1860 @default.
- Q37578137 P433 "8" @default.
- Q37578137 P478 "36" @default.
- Q37578137 P50 Q114334907 @default.
- Q37578137 P50 Q114421742 @default.
- Q37578137 P50 Q37605821 @default.
- Q37578137 P50 Q47262835 @default.
- Q37578137 P50 Q47264015 @default.
- Q37578137 P50 Q51425953 @default.
- Q37578137 P50 Q61799263 @default.
- Q37578137 P50 Q65660760 @default.
- Q37578137 P50 Q80623665 @default.
- Q37578137 P50 Q86652082 @default.
- Q37578137 P50 Q87413540 @default.
- Q37578137 P50 Q87727130 @default.
- Q37578137 P50 Q87999785 @default.
- Q37578137 P50 Q88560820 @default.
- Q37578137 P50 Q89313511 @default.
- Q37578137 P50 Q90114816 @default.
- Q37578137 P50 Q90114820 @default.
- Q37578137 P50 Q90209299 @default.
- Q37578137 P50 Q92095812 @default.
- Q37578137 P50 Q92451169 @default.
- Q37578137 P577 "2009-08-01T00:00:00Z" @default.
- Q37578137 P698 "19671813" @default.
- Q37578137 P921 Q187255 @default.
- Q37578137 P921 Q511097 @default.
- Q37578137 P921 Q864574 @default.